Digital Health Acquisition Overview
Digital Health Acquisition (DHAC) has a ROE of -211.26%, below the sector sector average of -4.47%.
Get informed when a big investor buys or sells
+ Follow-211.26%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for DHAC is -211.26%. That is below the sector sector average of -4.47%. Investors often review this figure alongside Digital Health Acquisition's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, DHAC currently prints -211.26% for ROE, while the sector average sits near -4.47%. That is roughly 4627.8% below the sector mean. Large gaps often invite a closer look at Digital Health Acquisition's growth, margins, and balance sheet.
Return on Equity shows how effectively Digital Health Acquisition converts resources into returns. At -211.26%, DHAC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting DHAC's ROE (-211.26%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
